Annovis Bio Interview to Air on Bloomberg International on the RedChip Money Report

Annovis Bio Interview to Air on Bloomberg International on the RedChip Money Report

BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, announced an interview with CEO Maria Maccecchini, Ph.D. will air on The RedChip Money Report television program.

The interview will air Sunday, September 6, at 6 p.m. local time on Bloomberg International, available in 100+ million homes across Europe.

In the exclusive interview, Dr. Maccecchini discusses the Company’s new approach to treating neurodegeneration as well as its active Phase 2a studies in AD and PD.

To view the interview segment, please visit:

The interview will also air in the US on the Family Channel on the Action Channel on Sunday, September 6, at 11 a.m. ET and is available via live stream on American Business TV.

READ:  UGI Declares Increased Common Dividend

“The RedChip Money Report” delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies.

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Disclosure: This site contains affiliate links to products, identified by the Affiliate Disclosure icon. MyChesCo may receive a commission for purchases made through these links.

Buy Us a Cup of Coffee